Vanguard Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1M | Buy |
966,705
+457,129
| +90% | +$22.3M | ﹤0.01% | 2146 |
|
|
2025
Q1 | $11M | Buy |
509,576
+292,072
| +134% | +$6.29M | ﹤0.01% | 2795 |
|
|
2024
Q4 | $5.85M | Buy |
217,504
+36,969
| +20% | +$994K | ﹤0.01% | 3211 |
|
|
2024
Q3 | $1.94M | Hold |
180,535
| – | – | ﹤0.01% | 3566 |
|
|
2024
Q2 | $2.16M | Buy |
180,535
+13,222
| +8% | +$158K | ﹤0.01% | 3531 |
|
|
2024
Q1 | $3.08M | Hold |
167,313
| – | – | ﹤0.01% | 3456 |
|
|
2023
Q4 | $2.66M | Buy |
167,313
+2,715
| +2% | +$43.1K | ﹤0.01% | 3500 |
|
|
2023
Q3 | $3.1M | Buy |
164,598
+4,267
| +3% | +$80.4K | ﹤0.01% | 3440 |
|
|
2023
Q2 | $3.62M | Hold |
160,331
| – | – | ﹤0.01% | 3452 |
|
|
2023
Q1 | $4.07M | Buy |
160,331
+36,873
| +30% | +$937K | ﹤0.01% | 3401 |
|
|
2022
Q4 | $1.87M | Buy |
123,458
+61
| +0% | +$923 | ﹤0.01% | 3682 |
|
|
2022
Q3 | $1.55M | Buy |
123,397
+315
| +0.3% | +$3.96K | ﹤0.01% | 3852 |
|
|
2022
Q2 | $1.2M | Hold |
123,082
| – | – | ﹤0.01% | 4017 |
|
|
2022
Q1 | $2.05M | Sell |
123,082
-767
| -0.6% | -$12.8K | ﹤0.01% | 3950 |
|
|
2021
Q4 | $3.15M | Buy |
123,849
+24,331
| +24% | +$618K | ﹤0.01% | 3856 |
|
|
2021
Q3 | $4.46M | Buy |
99,518
+196
| +0.2% | +$8.78K | ﹤0.01% | 3729 |
|
|
2021
Q2 | $4.01M | Sell |
99,322
-7,734
| -7% | -$312K | ﹤0.01% | 3701 |
|
|
2021
Q1 | $5.7M | Buy |
107,056
+12,048
| +13% | +$641K | ﹤0.01% | 3462 |
|
|
2020
Q4 | $3.8M | Sell |
95,008
-36,362
| -28% | -$1.45M | ﹤0.01% | 3479 |
|
|
2020
Q3 | $7.49M | Buy |
131,370
+47,473
| +57% | +$2.71M | ﹤0.01% | 2938 |
|
|
2020
Q2 | $6.19M | Buy |
83,897
+20,733
| +33% | +$1.53M | ﹤0.01% | 3002 |
|
|
2020
Q1 | $3.13M | Buy |
63,164
+29,210
| +86% | +$1.45M | ﹤0.01% | 3165 |
|
|
2019
Q4 | $2.61M | Hold |
33,954
| – | – | ﹤0.01% | 3373 |
|
|
2019
Q3 | $1.36M | Sell |
33,954
-1,928
| -5% | -$76.9K | ﹤0.01% | 3566 |
|
|
2019
Q2 | $1.21M | Sell |
35,882
-12,435
| -26% | -$418K | ﹤0.01% | 3617 |
|
|
2019
Q1 | $2.56M | Buy |
48,317
+5,030
| +12% | +$267K | ﹤0.01% | 3370 |
|
|
2018
Q4 | $2.03M | Buy |
43,287
+10,263
| +31% | +$482K | ﹤0.01% | 3371 |
|
|
2018
Q3 | $2.91M | Buy |
33,024
+4,299
| +15% | +$378K | ﹤0.01% | 3411 |
|
|
2018
Q2 | $2.99M | Buy |
28,725
+470
| +2% | +$48.9K | ﹤0.01% | 3379 |
|
|
2018
Q1 | $2.26M | Sell |
28,255
-28
| -0.1% | -$2.24K | ﹤0.01% | 3419 |
|
|
2017
Q4 | $3.85M | Buy |
28,283
+644
| +2% | +$87.6K | ﹤0.01% | 3232 |
|
|
2017
Q3 | $4.48M | Buy |
27,639
+12,612
| +84% | +$2.04M | ﹤0.01% | 3161 |
|
|
2017
Q2 | $2.25M | Sell |
15,027
-2,132
| -12% | -$320K | ﹤0.01% | 3345 |
|
|
2017
Q1 | $2.68M | Buy |
17,159
+535
| +3% | +$83.5K | ﹤0.01% | 3286 |
|
|
2016
Q4 | $3.46M | Buy |
16,624
+7,345
| +79% | +$1.53M | ﹤0.01% | 3184 |
|
|
2016
Q3 | $2.13M | Buy |
9,279
+667
| +8% | +$153K | ﹤0.01% | 3370 |
|
|
2016
Q2 | $1.78M | Buy |
8,612
+499
| +6% | +$103K | ﹤0.01% | 3410 |
|
|
2016
Q1 | $2.06M | Buy |
8,113
+1,386
| +21% | +$352K | ﹤0.01% | 3370 |
|
|
2015
Q4 | $2.31M | Buy |
6,727
+1,718
| +34% | +$590K | ﹤0.01% | 3337 |
|
|
2015
Q3 | $1.28M | Buy |
5,009
+697
| +16% | +$177K | ﹤0.01% | 3550 |
|
|
2015
Q2 | $1.21M | Buy |
+4,312
| New | +$1.21M | ﹤0.01% | 3605 |
|